JERUSALEM, Jan. 6, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and offering CDMO services through its Scinai Bioservices unit, announced...
Hence then, the article about scinai to connect with investors and pharma leaders at upcoming key us conferences was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences )
Also on site :
- Russia-Ukraine war: List of key events, day 1,426
- Rangers’ Cody Bradford Targeting Return In May From Elbow Surgery
- '90s Trash Metal Band Releases New Single Ahead of Farewell Album